Biomedicine and healthcare have long been among the most important industries of the Zhangjiang National Innovation Demonstration Zone in Shanghai. In recent years, Zhangjiang has been establishing public service platforms to further serve the development of its coreindustries.
April 14, 2017, Chengde Medical University Affiliated Hospital and Shanghai Biotecan Medical Pharmaceuticals Co., Ltd. attended a signing ceremony in the South District of Chengde Medical University Affiliated Hospital, commit to build "Chengde Regional Molecular Medicine Center together."
Ring out the old year and ring in the new!With the arrival of the splendid sunshine of the Spring Festival in 2017, we will bid farewell to the challenging and fruitful 2016 years, ushering in the year 2017, full of hope and hard work. On behalf of the Board of Directors and the management team, I would like to extend my sincerely thanks and best wishes to all our colleagues and their families who have devoted their efforts to the development of the company in the past year and to all the friends who care for the development of the company.With the most sincere greetings and deep respect for the Chinese New Year
The professor of Beckman Research Institute and City of Hope Comprehensive Cancer Center and chiefscientist of Zhangjiang Center for Translational Medicine, YuHua published the paper in Immunity
First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China